Previous Page  20 / 48 Next Page
Information
Show Menu
Previous Page 20 / 48 Next Page
Page Background

PROFILE 1014: PFS

(ITT Population)

10.9

vs.

7 m

HR 0.45

Solomon BJ, et al. N Engl J Med 2014

Approximately

half of patients

treated with

crizotinib

progress in the

CNS